Health News from Medical News Today
Latest Health News and Medical News posted throughout the day, every day.
- Last build:
- Language:
- en-us
- Feed URL:
- http://www.medicalnewstoday.com/medicalnews.xml
RSS FEED IDEMS: Health News from Medical News Today
- Macular Degeneration Could Be Affected By Genetic Variant
Genetic variations that affect the production of various chemicals inthe inflammation pathways could provide more information about agerelated macular degeneration (AMD), according to research released inthe British Journalof Ophthalmology on February 28, 2008.AMD is aprogressive eye diseases which affects the center of the retina, knownas the macula, at the back of the eye.
Tue, 11 Mar 2008 00:00:00 PDT - Femara Helps Protect Against Return Of Breast Cancer Even When Treatment Starts Several Years After Completing Tamoxifen Therapy
Women may reduce the risk of their breast cancer returning by starting treatment with Femara® (letrozole tablets) anywhere from one to seven years after finishing tamoxifen therapy, according to a new analysis published in the Journal of Clinical Oncology1.
Tue, 11 Mar 2008 00:00:00 PDT - Cosmetic Injectables No Contest Or Party
Hot lips contests and pump parties are taking on new meaning, but cosmetic injectables should never be offered or accepted as contest prizes or in a party setting, warns the Physicians Coalition for Injectable Safety.
Tue, 11 Mar 2008 00:00:00 PDT - Macular Degeneration More Than Doubles Heart Attack And Stroke Risk
Age related macular degeneration (AMD) doubles the risk of dying from aheart attack, according to research released on February 28, 2008 inthe British Journal of Opthamology. AMD is a progressive eye diseases which affects the center of theretina, known as the macula, at the back of the eye.
Tue, 11 Mar 2008 00:00:00 PDT - Society Of Gynecologic Oncologists 39th Annual Meeting On Women's Cancer To Include Sessions On HPV And Cervical Cancer
It has been almost two years since the first vaccine to prevent cervical cancer was approved for regular clinical use, and the Society of Gynecologic Oncologists (SGO), the professional association for experts in women's cancer, will take a critical look at HPV and Cervical Cancer as well a
Tue, 11 Mar 2008 00:00:00 PDT - Cell Receptor On Track For Painless Bladder Cancer Test
The Medical University of South Carolina (MUSC) Foundation for Research and Development announced a promising new diagnostic tool to detect and monitor bladder cancer. Current tests for bladder cancer have shown to be accurate for only 40 percent of diagnoses.
Tue, 11 Mar 2008 00:00:00 PDT - Potential Brain Cancer Drug For Children May Damage Bones
A novel drug that fully eliminated brain tumors from mice in a dramatic 2004 study has shown a darker side -- causing permanent bone damage in younger mice. The researcher who conducted both studies says the disappointing new finding raises concerns about using similar drugs to treat children's cancers, at least until there is a more thorough understanding of possible risks.
Tue, 11 Mar 2008 00:00:00 PDT - Alseres Pharmaceuticals Presents Inosine And Dopamine Transporter (DAT) Blocker Preclinical Data At The ASENT Conference
Alseres Pharmaceuticals, Inc. (Nasdaq: ALSE) announced that data from preclinical studies of the Company's nerve repair candidate, Inosine, and DAT Blocker product candidates from its neurodegeneration program were presented at the ASENT conference, March 6-8, 2008 in Arlington, VA.
Tue, 11 Mar 2008 00:00:00 PDT - Hope For Crohn's Patients With Fistulas Found In HUMIRA/Adalimumab
At the recent European Crohn's and Colitis Organization (ECCO) annualmeeting in Lyon, France, Abbott Laboratories announced that HUMIRA(Adalimumab) is successful in the treatment of fistulas in susceptibleCrohn's patients. Crohn'sDisease (CD) is a gastrointestinal disorder which is indicated bychronicinflammation of the wall of the digestive tract.
Tue, 11 Mar 2008 00:00:00 PDT - Mayo Clinic Proceedings Contributors Highlight Research Findings About Cardiovascular Benefits Associated With Omega-3 Fatty Acids
Thousands of research studies have documented how the oils known as omega-3 fatty acids can benefit the cardiovascular system, particularly among people diagnosed with coronary artery disease. The incredible volume of research on this topic creates difficulty for many physicians and patients to stay current with findings and recommendations related to these oils.
Tue, 11 Mar 2008 00:00:00 PDT - Lupus - Working Together For A Cure
On Tuesday, March 4th, advocates for the Alliance for Lupus Research (ALR), on behalf of the 1.4 million Americans with lupus, described their personal experiences with the disease to their Members of Congress.
Tue, 11 Mar 2008 00:00:00 PDT - Anesiva Announces Submission Of Supplemental New Drug Application For Zingo(TM) To Reduce Pain Associated With Needle Insertion Procedures In Adults
Anesiva, Inc. (Nasdaq: ANSV) announced that the company has submitted a supplemental New Drug Application (sNDA) with the U.S. Food and Drug Administration (FDA) to expand the indication for Zingo to treat the pain associated with peripheral IV insertions and blood draws in adults.
Tue, 11 Mar 2008 00:00:00 PDT - Keryx Biopharmaceuticals Announces That SUN-MICRO Phase 3 Clinical Trial Fails To Meet Primary Efficacy Endpoint
On Friday, March 7, 2008, Keryx Biopharmaceuticals, Inc. (Nasdaq: KERX), announced top-line results from its SUN-MICRO Phase 3 clinical trial of Sulonex (sulodexide) for the treatment of diabetic nephropathy.
Tue, 11 Mar 2008 00:00:00 PDT - Palatin Technologies, Inc. Reports Positive Results Of A Phase I Clinical Study With PL-3994 For The Treatment Of Congestive Heart Failure
Palatin Technologies, Inc. (Amex: PTN) announced the completion of a Phase I clinical trial of PL-3994, a novel, long-acting natriuretic peptide receptor A (NPRA) agonist under development for treatment of acute decompensated congestive heart failure (CHF).
Tue, 11 Mar 2008 00:00:00 PDT - Cerimon To Conduct A Proof Of Concept Study For Basiliximab For Noninfectious Uveitis, A Potentially Sight-Threatening Inflammation Of The Eye
Cerimon Pharmaceuticals announced it has entered into an agreement with Novartis Pharma AG to conduct a proof of concept study for Simulect(R) (basiliximab) for the treatment of noninfectious uveitis, an autoimmune inflammation of the eye's internal structures. Uveitis can cause severe visual impairment and accounts for an estimated 10 percent of blindness cases in the Western World.
Tue, 11 Mar 2008 00:00:00 PDT
